Notification of Preliminary Results

RNS Number : 1638Z
Alliance Pharma PLC
04 February 2014
 



For immediate release

                                                    4 February 2014

 

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Notification of Preliminary Results

 

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, will announce its preliminary results for the year ended 31 December 2013 on Wednesday 26 March 2014.

 

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

 

For more information, or to register attendance, please contact Buchanan on 020 7466 5000.

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive


Richard Wright, Finance Director


 


Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles




Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Oliver Cardigan / Freddie Barnfield


Corporate Broking: David Poutney


 

 

Notes to editors:

 

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORLLFIEFTIVIIS
UK 100

Latest directors dealings